BACKGROUND AND PURPOSE: Flow-diverter stents modify intra-aneurysmal blood flow and induce the progressive thrombosis of intracranial aneurysms followed by stable vascular reconstruction. The aim of this study was to report a new method for the appraisal of intracranial blood flow from DSA performed during endovascular treatment procedures. MATERIALS AND METHODS: A cohort of 24 patients with unruptured IAs who underwent FDS implantation was prospectively recruited. Pre- and post-DSA sequences in combination with 3D rotational angiography were acquired. The quantification of arterial and intra-aneurysmal flow was accomplished by using an optical flow approach. Flow reduction was assessed by using a new metric termed the mean aneurysm flow amplitude ratio. The correlation between the MAFA ratio and the incidence of aneurysm thrombosis was assessed by using receiver operating characteristic analysis and the Fisher exact test when the optimum Youden index was found. RESULTS: The quantification of flow was successfully achieved in 21 of 24 patients (87.5%). On the imaging follow-up, 18 aneurysms developed complete thrombosis (87.5%) and 3 displayed residual circulation (12.5%). The threshold analysis of the MAFA ratio significantly predicted thrombosis at 12 months below a threshold of 1.03 (P=.035). There was no significant correlation between the time for complete occlusion of the aneurysm and contrast stagnation inside the aneurysm after treatment (P>.05). CONCLUSIONS: The MAFA ratio based on DSA flow quantification appears to be a reliable predictor for the assessment of stent treatment outcomes in this small study. These results open the door for perioperative flow quantification and provide indices that may help clinicians make appropriate intraprocedural decisions.
BACKGROUND AND PURPOSE: Flow-diverter stents modify intra-aneurysmal blood flow and induce the progressive thrombosis of intracranial aneurysms followed by stable vascular reconstruction. The aim of this study was to report a new method for the appraisal of intracranial blood flow from DSA performed during endovascular treatment procedures. MATERIALS AND METHODS: A cohort of 24 patients with unruptured IAs who underwent FDS implantation was prospectively recruited. Pre- and post-DSA sequences in combination with 3D rotational angiography were acquired. The quantification of arterial and intra-aneurysmal flow was accomplished by using an optical flow approach. Flow reduction was assessed by using a new metric termed the mean aneurysm flow amplitude ratio. The correlation between the MAFA ratio and the incidence of aneurysm thrombosis was assessed by using receiver operating characteristic analysis and the Fisher exact test when the optimum Youden index was found. RESULTS: The quantification of flow was successfully achieved in 21 of 24 patients (87.5%). On the imaging follow-up, 18 aneurysms developed complete thrombosis (87.5%) and 3 displayed residual circulation (12.5%). The threshold analysis of the MAFA ratio significantly predicted thrombosis at 12 months below a threshold of 1.03 (P=.035). There was no significant correlation between the time for complete occlusion of the aneurysm and contrast stagnation inside the aneurysm after treatment (P>.05). CONCLUSIONS: The MAFA ratio based on DSA flow quantification appears to be a reliable predictor for the assessment of stent treatment outcomes in this small study. These results open the door for perioperative flow quantification and provide indices that may help clinicians make appropriate intraprocedural decisions.
Authors: Odile Bonnefous; Vitor Mendes Pereira; Rafik Ouared; Olivier Brina; Hans Aerts; Roel Hermans; Fred van Nijnatten; Jean Stawiaski; Daniel Ruijters Journal: Med Phys Date: 2012-10 Impact factor: 4.071
Authors: I Szikora; Z Berentei; Z Kulcsar; M Marosfoi; Z S Vajda; W Lee; A Berez; P K Nelson Journal: AJNR Am J Neuroradiol Date: 2010-02-11 Impact factor: 3.825
Authors: Olivier N Naggara; Phil M White; François Guilbert; Daniel Roy; Alain Weill; Jean Raymond Journal: Radiology Date: 2010-07-15 Impact factor: 11.105
Authors: David O Wiebers; J P Whisnant; J Huston; I Meissner; R D Brown; D G Piepgras; G S Forbes; K Thielen; D Nichols; W M O'Fallon; J Peacock; L Jaeger; N F Kassell; G L Kongable-Beckman; J C Torner Journal: Lancet Date: 2003-07-12 Impact factor: 79.321
Authors: Y Wu; G Shaughnessy; C A Hoffman; E L Oberstar; S Schafer; T Schubert; K L Ruedinger; B J Davis; C A Mistretta; C M Strother; M A Speidel Journal: AJNR Am J Neuroradiol Date: 2018-09-13 Impact factor: 3.825
Authors: Fernando Mut; Bong Jae Chung; Jorge Chudyk; Pedro Lylyk; Ramanathan Kadirvel; David F Kallmes; Juan R Cebral Journal: Int J Numer Method Biomed Eng Date: 2019-04-11 Impact factor: 2.747
Authors: Ronak J Dholakia; Ari D Kappel; Andrew Pagano; Henry H Woo; Baruch B Lieber; David J Fiorella; Chander Sadasivan Journal: Interv Neuroradiol Date: 2017-12-14 Impact factor: 1.610
Authors: Bongjae Chung; Fernando Mut; Ramanathan Kadirvel; Ravi Lingineni; David F Kallmes; Juan R Cebral Journal: J Neurointerv Surg Date: 2014-10-20 Impact factor: 5.836
Authors: P Bouillot; O Brina; H Yilmaz; M Farhat; G Erceg; K-O Lovblad; M I Vargas; Z Kulcsar; V M Pereira Journal: AJNR Am J Neuroradiol Date: 2016-06-30 Impact factor: 3.825
Authors: O Brina; R Ouared; O Bonnefous; F van Nijnatten; P Bouillot; P Bijlenga; K Schaller; K-O Lovblad; T Grünhagen; D Ruijters; V Mendes Pereira Journal: AJNR Am J Neuroradiol Date: 2014-07-31 Impact factor: 3.825